Recent advances in the medicinal chemistry of novel erythromycin-derivatized antibiotics

Current Topics in Medicinal Chemistry

Volumn 10, Issue 14, 2010, Pages 1441-1469

  Ying, Lu ^a   Tang, Datong ^a  

^a Enanta Pharmaceuticals Inc   (United States)

Author keywords

Antibacterial; Erythromycin; Macrolide antibiotics; SAR

Indexed keywords

9 ACETYLIMINO 3 DEHEXAPYRANOSYLOXY 9 DEOXO 3 OXO 6 O,11 O [2 [6 (1 PYRAZOLYL) 3 PYRIDINYLMETHOXYIMINO]PROPYLENE]ERYTHROMYCIN; AZITHROMYCIN; BAL 19403; CEM 101; CETHROMYCIN; CLARITHROMYCIN; EDP 322; ERYTHROMYCIN; ERYTHROMYCIN DERIVATIVE; TELITHROMYCIN; UNCLASSIFIED DRUG;

ANTIBACTERIAL ACTIVITY; ARTICLE; CHEMICAL MODIFICATION; DERIVATIZATION; DRUG STRUCTURE; DRUG SYNTHESIS; STRUCTURE ACTIVITY RELATION;

ANTI-BACTERIAL AGENTS; AZITHROMYCIN; CHEMISTRY, PHARMACEUTICAL; CLARITHROMYCIN; DRUG RESISTANCE, MICROBIAL; ERYTHROMYCIN; HUMANS; KETOLIDES; MACROLIDES;

EID: 77955638589     PISSN: 15680266     EISSN: None     Source Type: Journal    
DOI: 10.2174/156802610792232042     Document Type: Article

References (72)

1. McGuire, J. M.; Bunch, R. L.; Anderson, R. C.; Boaz, H. E.; Flynn, E. H.; Powell, H. M.; Smith, J. W. "Ilotycin", a new antibiotic. Antibiot. Chemother., 1952, 2, 281.
2. Bunch, R. L.; McGuire, J. M. Erythromycin, its salts, and method of preparation. US Patent, 2653899, 1953.
3. Brisson-Noel, A.; Trieu-Cuot, P.; Courvalin, P. Mechanisms of action of spiramycin and other macrolides. J. Antimicrob. Chemother., 1988, 22 (Suppl B). 13-23
4. Harms, J.; Schluenzen, F.; Zarivech, R.; Bashan, A.; Gat, S.; Ag-mon, I.; Bartels, H.; Fraceschi, F.; Yonath, A. High resolution structure of the large ribosomal subunit from a mesophilic eubacte-rium. Cell, 2001, 707, 679.
5. Kurath, P.; Jones, P. H.; Egan,R. S.; Perun, T. J. Acid degradation of erythromycin A and erythromycin B. Experientia, 1971, 27, 362.
6. Finland, M; Wilcox, C.; Wright, S. S.; Purcell, E. M. Cross resistance to antibiotics: effect of exposures of bacteria to carbomycin or erythromycin in vitro. Proc. Soc. Exp. Biol. Med. 1952, 81, 725.
7. Leclercq, R.; Courvalin, P. Resistance to macrolides and related antibiotics in S. pneumoniae. Antimicrob. Agents Chemother., 2002, 46, 2727.
8. Morimoto, S.; Takahashi, Y.; Watanabe, Y. Chemical modification of erythromycins. I. Synthesis and antibacterial activity of 6-O-methylerythromycins A. J. Antibiot., 1984, 34, 187.
9. Watanabe, Y.; Morimoto, S.; Omura, S. Novel erythromycin compounds. US Patent 4331803, 1982 (Taisho clarithromycin).
10. Kobrehel, G.; Radobolja, G.; Tamburasev, Z.; Djokic, S. 11-Aza-10-deoxo-10 - dihydro erythromycin A and derivatives thereof as well as a process for their preparation. US Patent, 4328334, 1982.
11. Djokic, S.; Kobrehel, G.; Lopotar, N.; Kamenar, B.; Nagl, A.; Mrvos, D. Erythromycin series. Part 13. Synthesis and structure elucidation of 10-dihydro-10-deoxo-11-methyl-11-azaerythromycin. J. Chem. Res. (S), 1988, 152.
12. Bright, M.; Nagel, A. A.; Bordner, J.; Deasi, K. A.; Dibrino, J. N.; Nowakowski, J.; Vincent, L.; Watrous, R. M.; Sciavolino, F. C.; English, A. R.; Retsema, J. A.; Anderson, M. R.; Brennan, L. A.; Borovoy, R. J.; Cimochowski, C. R.; Faiella, J. A.; Girard, A. E.; Girard, D.; Herbert, C.; Manousos, M.; Mason, R. Synthesis, in vitro and in vivo activity of novel 9-deoxo-9a-aza-9a-homoerythromycin A derivatives; a new class of macrolide antibiotics, the azalides. J. Antibiot., 1988, 41, 1029.
13. Scheinfeld, N. Telithromycin: a brief review of a new ketolide antibiotic. J. Drug Dermatol., 2004, 3(4),409-413.
14. Hammerschlag, M. R.; Sharma, R. Use of cethromycin, a new ketolide, for treatment of community-acquired respiratory infections. Exp. Opin. Investig. Drugs, 2008, 17, 387.
15. Lemaire, S.; Van Bambeke, F.; Tulkens, P. M. Cellular accumulation and pharmacodynamic evaluation of the intracellular activity of CEM-101, a novel fluoroketolide, against Staphyloccocus aureus, Listeria monocytogenes, and Legionella pneumophila in human THP-1 macrophages. Antimicrob. Agents Chemother., 2009, 53, 3734.
16. Morrison, T. Cempra closes $46M series C for trials of two antibiotics. Bioworld Today, 2009, 20, 1.
17. Revill, P.; Bolos, J.; Serradell, N. EDP-420. Drugs Future, 2006, 31, 479.
18. th, 2008.
19. th, 2007.
20. Kaneko, T.; Dougherty, T. J.; Magee, T. V. Macrolide Antibioyics. Comprehensive Medicinal Chemistry II; Triggle, D. J.; Taylor, J. B.; Eds.; Elsevier: Oxford, Vol. 7, 519-566. 2006,
21. Pal, S. A journey across the sequential development of macrolides and ketolides related to erythromycin. Tetrahedron, 2006, 62, 3171.
22. Baker, W. R.; Clark, J. D. Semisynthetic erythromycin antibiotics. U.S. Patent 4742049, 1988.
23. Hwang, C.-K.; Duffield, J.; Chiu, Y.-H.; Liang, C.-H.; Yao, S.; Roberts, N.; Babakhani, F.; Sears, P.; Shue, Y.-K.; Ichikawa, Y.; Fernandes, P.; Pereira, D.; Romero, A. SAR of 11, 12-carbamate macrolides/ketolides linked with 1,4-substituted-[1,2,3]-triazoles. ICAAC/IDSA 2008, Poster #F1-3973.
24. Waites, K. B.; Crabb, D. M.; Duffy, L. B. Comparative in vitro susceptibilities of human mycoplasmas and ureaplasmas to a new investigational ketolides, CEM-101. Antimicrob. Agents Che-mother. 2009, 53, 2139.
25. Liang, C.-H.; Yao, S.; Chiu, Y.-H.; Leung, P. Y.; Robert, N.; Sed-don, J.; Sears, P.; Hwang, C.-K.; Ichikawa, Y.; Romero, A. Synthesis and biological activity of new 5-O-sugar modified ketolide and 2-fluoro-ketolide antibitics. Bioorg. Med. Chem. Lett., 2005, 15, 1307.
26. Romero, A.; Liang, C.-H.; Chiu, Y.-H.; Yao, S.; Duffield, J.; Sucheck, S. J.; Marby, K.; Rabuka, D.; Leung, P. Y.; Shue, Y.-K.; Ichikawa, Y.; Hwang, C.-K. A efficient entry to new sugar modified ketolide antibiotics. Tetrahedron Lett., 2005, 46, 1483.
27. Hunziker, D.; Wyss, P.-C.; Angehrn, P.; Mueller, A.; Marty, H.-P.; Halm, R.; Kellenberger, L.; Bitsch, V.; Biringer, G.; Arnold, W.; Stampfli, A.; Schmitt-Hoffmann, A.; Cousot, D. Novel ketolide antibiotics with a fused five-membered lactone ring-synthesis, phys-icochemical and antimicrobial properties. Bioorg. Med. Chem. Lett., 2004, 14, 3503.
28. Heller, S.; Kellenberger, L.; Shapiro, S. Antipropionibacterial activity of BAL19403, a novel macrolide antibiotic. Antimirob. Agents Chemother., 2007, 51, 1956.
29. Xu, P.; Liu, L.; Chen, X.-Z.; Li, Y.; Liu, J.; Jin, Z.-P.; Wang, G.-Q.; Lei, P.-S. Synthesis of novel macrolide derivatives with imi-dazo[4,5-b]pyridinyl sulfur contained side chains and their antibacterial activity. Bioorg. Med. Chem. Lett., 2009, 19, 4079.
30. 12 vinyl ketolides. J. Med. Chem., 2006, 49, 1730.
31. 12 des-methyl ketolides. Bioorg. Med. Chem. Lett., 2006, 16, 4692.
32. 12 ethyl ketolides. Bioorg. Med. Chem., 2006, 14, 5592.
33. Kaneko, T.; Romero, K.; Li, B.; Buzon, R. Novel tethers in ketol-ide antibiotics. Bioorg. Med. Chem. Lett., 2007, 17, 5049.
34. Xu, P.; Liu, L.; Jin, Z.-P.; Wang, G.-Q.; Liu, J.; Li, Y.; Lei, P.-S. Synthesis and antibacterial activity of 4″-O-heteroarylcarbamoyl derivatives of macrolide. Bioorg. Med. Chem. Lett. 2008, 18, 5507.
35. Fernandes, P. B.; Baker, W. R.; Freiberg, L. A.; Hardy, D.; McDonald, E. New macrolides active against Streptococcus pyo-genes with inducible or constitutive type of macrolide-lincosamide-streptogramin B resistance. Antimicrob. Agents Chemother., 1989, 331, 78.
36. Baker, W. R.; Clark, J. D.; Stephens, R. L.; Kim, K. H. Modification of macrolide antibiotics. Synthesis of 11-deoxy-11-(carboxy-amino)-6-O-methylerythromycin A 11,12-(cyclic esters) via an intramolecular Michael reaction of O-carbamates with an.alpha.,.beta.-unsaturated ketone. J. Org. Chem., 1988, 53, 2340.
37. Plata, D. J.; Leanna, M. R.; Rasmussen, M.; McLaughlin, M. A.; Condon, S. L.; Kerdesky, F. A. J.; King, S. A.; Peterson, M. J.; Stoner, E. J.; Wittenberger, S. J. The synthesis of ketolide antibiotic ABT-773 (cethromycin). Tetrahedron, 2004, 60, 10171.
38. Beebe, X.; Yang, F.; Bui, M. H.; Mitten, M. J.; Ma, Z.; Nilius, A. M.; Djuric, S. W. Synthesis and antibacterial activity of 6-O-arylpropargyl-9-oxime-11,12-carbamate ketolides. Bioorg. Med. Chem. Lett., 2004, 14, 2417.
39. Yong, H.; Gu, Y. G.; Clark, R. F.; Marron, T.; Ma, Z.; Soni, N.; Stone, G. G.; Nilius, A. M.; Marsh, K.; Djuric, S. Design, synthesis and structure-activity relationships of 6-O-arylpropargyl diazalides with potent activity against multidrug-resistant Streptococcus pneumoniae. Bioorg. Med. Chem. Lett., 2005, 15, 2653.
40. Ono, T.; Kashimura, M.; Suzuki, K.; Oyauchi, R.; Miyachi, J.; Ikuta, H.; Kawauchi, H.; Akashi, T.; Asaka, T.; Morimoto, S. In vitro and in vivo antibacterial activities of the tricyclic ketolide TE-802 and its analogs. J. Antibiot., 2004, 57, 518.
41. Henninger, T. C.; Xu, X.; Abbanat, D.; Baum, E. Z.; Foleno, B. D.; Hilliard, J. J.; Bush, K.; Hlasta, D. J.; Macielag, M. J. Synthesis and antibacterial activity of C-6 carbamate ketolides, a novel series of orally active ketolide antibiotics. Bioorg. Med. Chem. Lett., 2004, 14, 4495.
42. Xu, X.; Henninger, T. C.; Abbanat, D.; Bush, K.; Foleno, B. D.; Hilliard, J. J.; Macielag, M. J. Synthesis and antibacterial activity of C2-fluoro, C6-carbamate ketolides, and their C9-oximes. Bioorg. Med. Chem. Lett., 2005, 15, 883.
43. Bin, Z.; Marinelli, B. A.; Abbanat, D.; Foleno, B. D.; Henninger, T. C.; Bush, K.; Macielag, M. J. Synthesis and antibacterial activity of 3-O-acyl-6-O-carbamoyl erythromycin A derivatives. Bioorg. Med. Chem. Lett., 2006, 16, 1054.
44. Grant, E. B.; Guiadeen, D.; Abbanat, D.; Foleno, B.; Macielag, M. J. Synthesis and antibacterial activity of 6-O-heteroarylcarbamoyl-11,12-lactoketolides. Bioorg. Med. Chem. Lett., 2006, 16, 1929.
45. Bin, Z.; Marinelli, B. A.; Abbanat, D.; Foleno, B. D.; Bush, K.; Macielag, M. J. Synthesis and antibacterial activity of 3-keto-6-O-carbamoyl-11,12-cyclic thiocarbamate erythromycin A derivatives. Bioorg. Med. Chem. Lett., 2007, 17, 3900.
46. Tennakoon, M. A.; Henninger, T. C.; Abbanat, D.; Foleno, B. D.; Bush, K.; Hilliard, J. J.; Bush, K.; Macielag, M. J. Synthesis and antibacterial activity of C6-carbazate ketolides. Bioorg. Med. Chem. Lett., 2006, 16, 6231.
47. Mutak, S. Azalides from azithromycin to new azalide derivatives. J. Antibiot., 2007, 60, 85.
48. Istuk, Z. M.; Mutak, S.; Kujundzic, N.; Kragol, G. Novel 9a-carbamoyl- and 9a-thiocarbamoyl-3-decladinosyl-6-hydroxy and 6-methoxy derivatives of 15-membered macrolides. Bioorg. Med. Chem., 2007, 15, 4498.
49. Bhattecharjee, A.; Beard, H.; Devito, J.; Farmer, J.; Franceschi, F.; Gould, T.; Ippolito, J.; Johnson, G.; Kanyo, Z.; Lawrence, L.; Mar-tynow, J.; McConnell, T.; Sherer, E.; Sutcliffe, J.; Tang, Y.; Tow-Keogh, C.; Wang, D.; Wimberly, B.; Wu, Y.; Duffy, E. Structure- based drug design targeting infectious disease: Overcoming resistance and extending the antimicrobial spectrum of macrolide antibiotics. Gordon Conference on Medicinal Chemistry, 2008.
50. Farmer, J. J.; Bhattecharjee, A.; Chen, Y.; Goldberg, J. A.; Ippolito, J. A.; Kanyo, Z. F.; Lou, R.; Oyelere, A. K.; Sherer, E. C.; Sut-cliffe, J. A.; Wang, D.; Wu, Y.; Du, Y. Macrocyclic compounds and methods of making and using the same. PCT Patent Application, WO0585266A2, 2005.
51. Ma, S.; Jiao, B.; Liu, Z.; Wang, H.; Xian, R.; Zheng, M.; Lou, H. Synthesis and antibacterial activity of 4″,11-di-0-arylalkylcarbamoyl azithromycin derivatives. Bioorg. Med. Chem. Lett., 2009, 19, 1698.
52. Ma, S.; Ma, R.; Liu, Z.; Ma, C.; Shen, X. Synthesis and antibacterial activity of novel 15-membered macrolide derivatives: 4″-Carbamate, 11,12-cyclic carbonate-4-carbamate and 11,4-di-O-arylcarbamoyl analogs of azithromycin. Eur. J. Med. Chem., 2009, 44, 4010.
53. Krajacic, M. B.; Novak, P.; Dumic, M.; Cindric, M.; Paljetak, H. C.; Kujundzic, N. Novel ureas and thioureas of 15-membered azalides with antibacterial activity against key respiratory pathogens. Eur. J. Med. Chem., 2009, 44, 3459.
54. Krajacic, M. B.; Novak, P.; Cindric, M.; Brajsa, K.; Dumic, M.; Kujundzic, N. Azithromycine-sulfonamide conjugates as inhibitors of resistant Streptococcus pyogenes strains. Eur. J. Med. Chem., 2007, 42, 138.
55. Krajacic, M. B.; Kujundzic, N.; Dumic, M.; Cindric, M.; Brajsa, K.; Metelko, B.; Novak, P. Synthesis, characterization and in vitro antimicrobial activity of novel sulfonylureas of 15-membered azalides. J. Antibiot., 2005, 58, 380.
56. Wang, G.; Niu, D.; Qiu, Y.-L.; Phan, L. T.; Chen, Z.; Polemero-poulos, A.; Or, Y. S. Synthesis of novel 6,11-O-bridged bicyclic ketolides via a palladium-catalyzed bis-allylation. Org. Lett., 2004, 6, 4455.
57. Kim, H.; Wang, G.; Or, Y. S.; Wang, Z. Process for the preparation of 6,11-bicyclic erythromycin derivatives. US Patent, US7022679, 2005.
58. Xu, G.; Gai, Y.; Wang, G.; Or, Y. S.; Wang, Z. Processes for the preparation of 0-(2-aminobenzo[d]oxazol-5-yl)methyl hydroxy-lamine for the synthesis of 6,11-bicyclic erythromycin derivative EDP-182. US Patent, US7563877, 2009.
59. Jiang, L.-J.; Wang, M.; Or, Y. S. Pharmacokinetics of EDP-420 after ascending single oral doses in healthy adult volunteers. Antim-icrob. Agents Chemother., 2009, 53, 1786.
60. Jiang, L.-J.; Or, Y. S. Pharmacokinetics of EDP-420 after multiple oral doses in healthy adult volunteers and in a bioequivalence study. Antimicrob. Agents Chemother., 2009, 53, 1786.
61. Bermudez, L. E.; Motamedi, N.; Chee, C.; Baimukanova, G.; Kolonoski, P.; Inderlied, C.; Aralar, P.; Wang, G.; Phan, L. T.; Young, L. S. EDP-420, a bicyclolide (bridged bicyclic macrolide), is active against Mycobacterium avium. Antimicrob. Agents Che-mother., 2007, 51, 1666. hris
62. Bermudez, L. E.; Motamedi, N.; Kolonoski, P.; Chee, C; Baimuka-nova, G.; Bildfell, R.; Wang, G.; Phan, L. T.; Young, L. S. The efficacy of clarithromycin and the bicyclolide EDP-420 against My-cobacterium avium in a mouse model of pulmonary infection. J. Infect. Dis., 2008, 197, 1506.
63. Stucki, A.; Gerber, P.; Acosta, F.; Cottagnoud, M.; Cottagnoud, P.; Jiang, L.-J.; Nguyen, P.; Wachtel, D.; Wang, G.; Phan, L. T. Effects of EDP-420 on penicillin-resistant and quinolone- and penicillin-resistant pneumococci in the rabbit meningitis model. J. Antimicrob. Chemother., 2008, 61, 655.
64. Gai, Y.; Tang, D.; Xu, G.; Chen, Z.; Polemeropoulos, A.; Wang, Z.; Or, Y. S. Synthesis of 3,6-bicyclolides: A novel class of macrol-ide antibiotics. Bioorg. Med. Chem. Lett., 2008, 18, 6315.
65. Tang, D.; Gai, Y.; Chen, Z.; Polemeropoulos, A.; Wang, Z.; Or, Y. S. Design, synthesis, and antibacterial activities of novel 3,6-bicyclolide oximes: Length optimization and zero carbon linker oximes. Bioorg. Med. Chem. Lett., 2008, 18, 5078.
66. Akritopoulou-Zanze, I.; Phelan, K. M.; Marron, T. G.; Yong, H.; Ma, Z.; Stone, G. G.; Daly, M. M.; Hensey, D. M.; Nilius, A. M.; Djuric, S. W. Synthesis and antibacterial activity of novel bifunc-tional macrolides. Bioorg. Med. Chem. Lett., 2004, 14, 3809.
67. Nomura, T.; Yasukata, T.; Narukawa, Y.; Uotani, K. 9-Oxime-3-ketolides: Modification at the C-11,12-diol moiety and antibacterial activities against key respiratory pathogens. Bioorg. Med. Chem., 2005, 13, 6054.
68. Nomura, T.; Iwaki, T.; Yasukata, T.; Nishi, K.; Narukawa, Y.; Uotani, K.; Hori, T.; Miwa, H. A new type of ketolides bearing an N-aryl-alkyl acetamide moiety at the C-9 imino ether synthesis and structure-activity relationships. Bioorg. Med. Chem., 2005, 13, 6615.
69. Nomura, T.; Iwaki, T.; Narukawa, Y.; Uotani, K.; Hori, T.; Miwa, H. A new type of ketolides bearing an N-aryl-alkyl acetamide moiety at the C-9 imino ether synthesis and structure-activity relationships (2). Bioorg. Med. Chem., 2006, 14, 3697.
70. Nam, G.; Kang, T.W.; Shin, J. H.; Choi, K. I. Design, synthesis, and anti-Helicobacter pylori activity of erythromycin A (E)-9-oxime ether derivatives. Bioorg. Med. Chem. Lett., 2006, 16, 569.
71. Xu, P.; Liu, L.; Jin, Z.; Lei, P. Synthesis and antibacterial activity of derivatives of 6-O-allylic acylides. Bioorg. Med. Chem. Lett., 2007, 17, 3330.
72. Sugawara, A.; Sunazuka, T.; Hirose, T.; Nagai, K.; Yamaguchi, Y.; Hanaki, H.; Sharpless, K. B.; Omura, S. Design and synthesis via click chemistry of 8,9-anhydroerythromycin A 6,9-hemiketal analogues with anti-MRSA and -VRE activity. Bioorg. Med. Chem. Lett., 2007, 17, 6340.